Stock CENBF CEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CEN Biotech, Inc.

Equities

CENBF

CA15130L1040

Market Closed - OTC Markets
Other stock markets
 09:50:21 2024-07-09 am EDT 		5-day change 1st Jan Change
0.000001 USD -99.50% Intraday chart for CEN Biotech, Inc. 0.00% -99.97%
2023 CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer CI
2022 CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
CEN Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
CEN Biotech, Inc. (OTCPK:CENB.F) completed the acquisition of Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux.
CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
CEN Biotech, Inc. (OTCPK:CENB.F) entered into a Share Exchange Agreement to acquire Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux for $5 million.
CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Cen Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
CEN Biotech, Inc. cancelled the acquisition of 70% of the outstanding common stock in the capital of AstralENERGY Solar Manufacturing Corporation, LTD.
CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
CEN Biotech, Inc. cancelled the acquisition of Caduceus Software Systems Corp. in a reverse merger transaction.
CI
Cen Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
CEN Biotech, Inc. entered into a non-binding term sheet to acquire Caduceus Software Systems Corp. in a reverse merger transaction.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CENBF Stock
  4. News CEN Biotech, Inc.
  5. Highlights